contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
      id
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    pageUrl
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


reclassification-of-class-c-shares-to-ordinary-shares-and-transfer-of-ordinary-shares-within-the-framework-of-a-long-term-incentive-plan

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Biotage

Uppsala, Sweden – 18 July, 2023 – The Annual General Meeting of Biotage AB (publ) (“Biotage”) resolved on June 4, 2020 to adopt a long-term incentive plan (“LTIP 2020”) which has now expired...

<div class="mfn-preamble"><p><strong>Uppsala, Sweden – 18 July, 2023 – The Annual General Meeting of Biotage AB (publ) (“Biotage”) resolved on June 4, 2020 to adopt a long-term incentive plan (“LTIP 2020”) which has now expired and for this reason, a total of 52,347 ordinary shares are transferred free of charge to the participants in LTIP 2020. To cover tax costs associated with LTIP 2020, some participants intend to sell a number of shares through Danske Bank A/S on Nasdaq Stockholm and, correspondingly, the company transfers a maximum of 17,960 ordinary shares to cover social contribution costs associated with LTIP 2020 which is expected to take place during the period 18 July 2023 until 24 July 2023, at a price within the registered price range at the relevant time. In order to enable the transfer of own ordinary shares, the Board of Directors has resolved to reclassify 70,307 class C shares into ordinary shares in accordance with the reclassification provision in the company’s Articles of Association.</strong></p></div><div class="mfn-body"><p>The company’s holding of own class C shares previously amounted to 729,817. Following the conversion of 70,307 class C shares and transfer of the corresponding number of ordinary shares, Biotage will hold 659,510 own class C shares.</p><p><em>This information was submitted for publication, through the agency of the contact persons set out above, at 13.00&nbsp;CEST on 18 July 2023.</em></p><p>Website: www.biotage.com</p></div><div class="mfn-footer mfn-contacts mfn-35d8da25c967"><p><strong class="mfn-heading-1">Contacts</strong></p><hr><p>Tomas Blomquist, President and CEO<br>Tel: 0705 23 01 63, <a rel="noopener" href="mailto:tomas.blomquist@biotage.com">tomas.blomquist@biotage.com</a></p></div><div class="mfn-footer mfn-about mfn-0a7046178eae"><p><strong class="mfn-heading-1">About Biotage</strong></p><hr><p>Biotage is a Global Impact Tech Company committed to solving society’s problems. We offer workflow solutions and products to customers in drug discovery and development and diagnostics, analytical testing and water and environmental testing.<br><br>Biotage is contributing to sustainable science with the goal to make the world a healthier, greener and cleaner place – HumanKind Unlimited.<br><br>Our customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research and contract manufacturers as well as clinical, forensic and academic laboratories in addition to organizations focused on food safety, clean water and environmental sustainability.<br><br>Biotage is headquartered in Uppsala in Sweden and employs appr. 700 people worldwide. The Group had sales of 1,566 MSEK in 2022 and our products are sold in more than 80 countries. Biotage’s share (BIOT) is listed in the Large Cap segment on the NASDAQ Stockholm.<br>Website: <a rel="noopener" href="https://www.biotage.com">www.biotage.com</a></p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong></p><hr><p><a rel="noopener" href="https://storage.mfn.se/5d83994e-8f2d-459f-a48d-b8c016c0b3a3/reclassification-of-class-c-shares-to-ordinary-shares-and-transfer-of-ordinary-shares-within-the-framework-of-a-long-term-incentive-plan.pdf" class="mfn-generated mfn-primary">Reclassification of class C shares to ordinary shares and transfer of ordinary shares within the framework of a long-term incentive plan</a></p></div>

Reclassification of class C shares to ordinary shares and transfer of ordinary shares within the framework of a long-term incentive plan